荷兰肾脏交换项目活体供肾移植的倾向性评分匹配分析:远期移植物存活与直接活体供肾移植相当
该研究纳入荷兰2004至2021年全部7536例活体供肾移植,其中694例(9%)经肾脏交换项目(KEP)完成。倾向性评分匹配后,KEP与非KEP的10年移植物存活率相似(0.916 vs 0.919,P=0.82)。KEP为缺乏相容供者的患者提供了可行替代方案,应优先于 deceased donor 移植、脱敏治疗和透析。
要点
- KEP受者10年移植物存活率与直接活体供肾移植相当(0.916 vs 0.919)。
- 匹配后5年排斥率和患者生存率差异无统计学意义。
- 高供者年龄、再移植、长透析龄、高PRA和肾病综合征为移植物存活降低的风险因素。
核心结论
- KEP活体供肾移植的长期移植物存活与直接活体供肾移植相当,应优先于 deceased donor 移植、脱敏治疗和透析。
研究设计与样本
- 荷兰2004至2021年所有活体供肾移植的回顾性队列研究,共7536例,其中KEP 694例(9%),采用倾向性评分匹配校正基线差异。
主要发现
- KEP与非KEP的10年移植物存活率分别为0.916(95%CI 0.894-0.939)和0.919(95%CI 0.912-0.926),P=0.82。
- 5年排斥率KEP为12%、非KEP为7%,5年患者生存率KEP为84%、非KEP为90%,倾向性评分匹配后差异无统计学意义。
- 移植物存活降低的显著风险因素包括高供者年龄、再移植、长透析龄、高群体反应性抗体(PRA)和以肾病综合征为ESKD病因。
临床怎么用
- KEP可作为缺乏相容供者患者的可行替代方案,避免脱敏治疗等侵入性预处理。
- 计划和管理移植前后护理时需考虑高供者年龄、再移植、长透析龄、高PRA和肾病综合征等风险因素。
- 无论供者出行还是移植物运输,KEP结局均可实现,为项目实施提供灵活性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: KEP recipients have comparable long-term graft survival to direct living donor kidney transplantation recipients, which underscores the need to prioritize KEP over other's therapies. Our outcomes can be achieved regardless of whether the donor travels or the graft is transported, offering flexibility in program implementation. BACKGROUND: KEPs (kidney exchange programs) facilitate living donor kidney transplantations (LDKTs) for patients with incompatible donors, who are typically at higher risk than non-KEP patients because of higher sensitization and longer dialysis vintage. We conducted a comparative analysis of graft outcomes and risk factors for both KEP and non-KEP living donor kidney transplants. METHODS: All LDKTs performed in The Netherlands between 2004 and 2021 were included. The primary outcome measures were 1-, 5-, and 10-year death-censored graft survival. The secondary outcome measures were delayed graft function, graft function, rejection rates, and patient survival. We used a propensity score–matching model to account for differences at baseline. RESULTS: Of 7536 LDKTs, 694 (9%) were transplanted through the KEP. Ten-year graft survival was similar for KEP (0.916; 95% confidence interval, 0.894 to 0.939) and non-KEP (0.919; 0.912 to 0.926, P = 0.82). We found significant differences in 5-year rejection (12% versus 7%) and 5-year patient survival (KEP: 84%, non-KEP: 90%), which was nonsignificant after propensity score matching. Significant risk factors of lower graft survival included high donor age, retransplantations, extended dialysis vintage, higher panel reactive antibodies, and nephrotic syndrome as the cause of ESKD. CONCLUSIONS: Transplantation through KEP offers a viable alternative for patients lacking compatible donors, avoiding specific and invasive pre- and post-transplant treatments. KEP's similar survival rate to non-KEPs suggests prioritizing KEP LDKTs over deceased donor kidney transplantation, desensitization, and dialysis. However, clinicians should consider the identified risk factors when planning and managing pre- and post-transplant care to enhance patient outcomes. Thus, we advocate for the broad adoption of KEP and establishment in regions lacking such programs, alongside initiation and expansion of international collaborations.
引用
- van de Laar SC, de Weerd AE, Bemelman FJ, et al. Favorable Living Donor Kidney Transplantation Outcomes within a National Kidney Exchange Program: A Propensity Score-Matching Analysis. Clin J Am Soc Nephrol. 2025. PMID: 39879095. doi:10.2215/CJN.0000000611
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。